Aloïs Gratwohl - Concepedia

Author

Aloïs Gratwohl

Also Known As

A Gratwohl, A. GRATWOHL, A. Gratwohl, A. Gratwohl, ALOIS GRATWOHL, Alois A. Gratwohl, Alois Gratwohl, Aloïs Gratwohl, C Nerl, D Niederwieser

785

Publications

46.1K

Citations

107

H-Index

212

Concepts

All Affiliations

University Hospital of Basel Kantonsspital Baselland University of Basel Radboud University Nijmegen Leiden University

About

Aloïs Gratwohl is an author at University Hospital of Basel specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	68	185	13.7K
2	Health Sciences	27	37	2.7K
3	Engineering	3	3	359
4	Management	2	2	201
5	Business	1	1	59

Aloïs Gratwohl

364

Publications

40.2K

Citations

101

H-Index

Page 1

	Year	Citations
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien, François Guilhot, Richard A. Larson, New England Journal of Medicine	2003	3.5K
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia Brian Druker, François Guilhot, Stephen G. O’Brien, New England Journal of Medicine	2006	3.5K
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten, New England Journal of Medicine	2009	818
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis Jacob M. van Laar, Dominique Farge, Jacob K. Sont, JAMA	2014	725
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE Philip A. Rowlings, Donna Przepiorka, John P. Klein, British Journal of Haematology	1997	685
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation Aloïs Gratwohl, J. Hermans, JM Goldman, The Lancet Risk AssessmentHematological MalignancyTransplantationMarrow TransplantationBone Marrow Failure	1998	649
Hematopoietic Stem Cell Transplantation<subtitle>A Global Perspective</subtitle> Aloïs Gratwohl JAMA	2010	643
Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation Els Goulmy, R.F. Schipper, Jos Pool, New England Journal of Medicine	1996	604
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Richard E. Champlin, Norbert Schmitz, Mary M. Horowitz, PubMed	2000	508
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck, Blood	2007	470

Page 1